Linden Thomas Advisory Services
FLGT icon

Linden Thomas Advisory Services’s Fulgent Genetics FLGT Stock Holding History

Linden Thomas Advisory Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$254K Sell
11,546
-207
-2% -$4.16K 0.02% 523
2026
Q2 		$241K Sell
11,753
-105
-0.9% -$1.78K 0.02% 514
2026
Q1 		$189K Buy
+11,858
New +$257K 0.02% 528

Other funds holding FLGT

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Linden Thomas Advisory Services's FLGT Position: Q3 2026 in Review

Linden Thomas Advisory Services reduced its Fulgent Genetics (FLGT) stake by 1.8% in Q3 2026, selling an estimated $4.16K and leaving 11,546 shares worth $254K. The position accounts for 0.02% of the portfolio, ranked #523.

Linden Thomas Advisory Services first reported a position in FLGT in Q1 2026 and has held it in 3 quarters since. 47 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Linden Thomas Advisory Services held 11,546 shares of Fulgent Genetics worth $254K as of Q3 2026.
  • Linden Thomas Advisory Services sold 207 Fulgent Genetics shares in Q3 2026, an estimated $4.16K.
  • Fulgent Genetics made up 0.02% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #523 holding.
  • Linden Thomas Advisory Services first reported a position in Fulgent Genetics in Q1 2026 and has held it in 3 quarters since.
  • 47 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.